2015
DOI: 10.14800/ics.683
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophil/lymphocyte ratio: A promising prognostic marker in patients with chronic kidney disease

Abstract: Chronic kidney disease (CKD), especially end-stage renal disease (ESRD), is associated with high morbidity and mortality due to cardiovascular disease (CVD) and infection, two common complications of ESRD that may be related, in part, to chronic inflammation and protein-energy wasting (PEW). Recently, in a Japanese prospective cohort study, we reported that there was significantly higher risk for CVD-related events in CKD patients with an increased neutrophil/lymphocyte ratio (NLR) at the start of their dialys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 47 publications
(53 reference statements)
0
1
0
Order By: Relevance
“…The link between systemic inflammation and short-term AVF failure has been recently studied [15][16][17][18][19]. Among the recently most studied inflammatory markers in the literature, we mention the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) as having predictive roles in the negative evolution of patients with a cardiovascular pathology [20][21][22][23][24][25][26][27][28] and patients with chronic kidney disease (CKD), respectively [17,18,[29][30][31][32][33]. Another typical inflammatory marker is the systemic inflammatory index (SII), which predicts mortality and poor oncological pathology outcomes [34][35][36].…”
Section: Introductionmentioning
confidence: 99%
“…The link between systemic inflammation and short-term AVF failure has been recently studied [15][16][17][18][19]. Among the recently most studied inflammatory markers in the literature, we mention the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) as having predictive roles in the negative evolution of patients with a cardiovascular pathology [20][21][22][23][24][25][26][27][28] and patients with chronic kidney disease (CKD), respectively [17,18,[29][30][31][32][33]. Another typical inflammatory marker is the systemic inflammatory index (SII), which predicts mortality and poor oncological pathology outcomes [34][35][36].…”
Section: Introductionmentioning
confidence: 99%